Platelet transfusion therapy for medical and surgical patients

Cleveland Clinic Journal of Medicine

Volumn 63, Issue 4, 1996, Pages 245-250

  Hussein, Mohamad A ^a   Hoeltge, Gerald A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT;

BLOOD TOXICITY; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; HUMAN; REVIEW; SURGERY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0030056509     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.63.4.245     Document Type: Review

References (44)

1. Rossi EC. Pathophysiology of thrombocytopenia. In: Rossi EC, Simon TL, Sandler GS, eds. Principles of transfusion medicine. Baltimore: Williams and Wilkins, 1991:215-217.
2. Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969; 48:963-974.
3. Wessels P, Heyns A du P, Pieters H, Lotter MG, Badenhorst PN. An improved method for the quantification of the in vivo kinetics of a representative population of 111-In-labelled human platelets. Eur J Nucl Med 1985; 10:522-527.
4. Heyns A du P, Lotter MG, Badenhorst PN, et al. Kinetics, distribution and sites of destruction of 111-indium-labelled human platelets. Br J Haematol 1980; 44:269-280.
5. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 1966; 45:645-657.
6. Norol F, Kuentz M, Cordonnier C, et al. Influence of clinical status on the efficiency of stored platelet transfusion. Br J Haematol 1994; 86:125-129.
7. Hussein MA, Zuccaro K, Long T. Amphotericin-B does not adversely affect platelet recovery or survival when spaced by two hours from the platelet transfusion [abstract]. Blood 1995; 86:899a.
8. Hussein MA, Lee EJ, Schiffer CA. Platelet transfusions administered to patients with splenomegaly. Transfusion 1990; 30:508-510.
9. Hogge DE, Dutcher JP, Aisner J, Schiffer CA. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol 1983; 14:363-369.
10. Dutcher JP, Schiffer CA, Aisner J, Wiernik PH. Long-term follow-up of patients with leukemia receiving platelet transfusion: identification of a large group of patients who do not become alloimmunized. Blood 1981; 58:1007-1011.
11. Lee EJ, Schiffer CA. Serial measurement of lymphocytotoxic antibody and response to non matched platelet transfusions in alloimmunized patients. Blood 1987; 70:1727-1729
12. Yankee RA, Graff KS, Dowling R, Henderson ES. Selection of unrelated compatible platelet donors by lymphocyte HLA matching. N Engl J Med 1973; 288:760-764.
13. Schiffer CA, Keller C, Dutcher JP, Aisner J, Hogge D, Wiernik PH. Potential HLA-matched platelet donor availability for alloimmunized patients. Transfusion 1983; 23:286-289
14. Brand A, Sintnicolaas K, Claas FH, Eernisse JG. ABH antibodies causing platelet transfusion refractoriness. Transfusion 1986; 26:463-466.
15. Christie DJ, van Buren N, Lennon SS, Putnam JL. Vancomycin-dependent antibodies associated with thrombocytopenia and refractoriness to platelet transfusion in patients with leukemia. Blood 1990; 75:518-523.
16. McElligott MC, Menitove JE, Duquesnoy RJ, Hunter JB, Aster RH. Effect of HLA Bw4/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients. Blood 1982; 59:971-975.
17. Schiffer CA, O'Connell B, Lee EJ. Platelet transfusion for alloimmunized patients: Selective mismatching for HLA B12, an antigen with variable expression on platelets. Blood 1989; 74:1172-1176.
18. Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients Am J Hematol 1977; 2:219-226.
19. Hussein MA, Lee EJ, Fletcher R, Schifler CA. The effect of lymphocytotoxic antibody reactivity on the results of single antigen mismatch platelet transfusion to alloimmunized patients. Blood 1996; 87:3959-3962.
20. Friedberg RC, Donnelly SF, Mintz PD. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients. Transfusion 1994; 34:215-220.
21. O'Connell BA, Lee EJ, Rothko K, Hussein MA, Schiffer CA. Selection of histocompatible apheresis platelet donors by crossmatching random donor platelet concentrates. Blood 1992; 79:527-531.
22. Christie DJ, Howe RB, Lennon SS, Sauro SC. Treatment of refractoriness to platelet transfusion by protein A column therapy. Transfusion 1993; 33:234-242.
23. Hussein MA, Long T, Bolwell B, et al. Response to Prosorba A column in alloimmunized platelet refractory patients [abstract]. Transfusion 1994; 34(suppl):66S.
24. Schiffer CA, Lee EJ, Ness PM, Reilly J. Clinical evaluation of platelet concentrates stored for one to five days. Blood 1986; 67:1591-1594.
25. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995; 35:117-124.
26. Sharma S, Zuccaro K, Andresen S, Long T, Hussein MA. Premedication for platelet transfusion. A prospective study on four commonly used regimens [abstract]. Blood 1995; 86:354a.
27. Halpin TJ, Kiker S, Epstein J, Tourault M. Bacterial contamination of platelet pools - Ohio, 1991. MMWR 1992; 41:36-37.
28. Krishnan LA, Brecher ME. Transfusion-transmitted bacterial infection [review]. Hematol Oncol Clin North Am 1995; 9(1):167-185.
29. Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between count and hemorrhage in patients with acute leukemia. N Engl J Med 1962; 266:905-909.
30. Heyman MR, Schiffer CA. Platelet transfusion therapy for the cancer patient. Semin Oncol 1990; 17:198-209.
31. Beutler, R. Platelet transfusions: The 20,000/μL trigger. Blood: 1993; 81:1411-1413.
32. Solomon J, Bofenkamp T, Fahey, JL, Chillar RK, Beutel E. Platelet prophylaxis in acute non-lymphoblastic leukaemia [letter]. Lancet 1978; 1:267.
33. Murphy S, Litwin S, Herring LM, et al. Indications for platelet transfusion in children with acute leukemia. Am J Hematol 1982; 12:347-356.
34. Gmür J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991; 338:1223-1226.
35. Bishop JF, Schiffer CA, Aisner J, Matthews JP, Wiernik PH. Surgery in acute leukemia. A review of 167 operations in thrombocytopenic patients. Am J Hematol 1987; 26:147-155.
36. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guideline Development Task Force of the College of American Pathologists. Practice parameter for the use of fresh-frozen plasma, Cryoprecipitate, and platelets. JAMA 1994; 271:777-781.
37. Simon TL, Akl F, Murphy W. Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Ann Thorac Surg 1984; 37:359-364.
38. Carr JM, Kruskall MS, Kaye JA, Robinson SH. Efficacy of platelet transfusions in immune thrombocytopenia. Am J Med 1986; 80:1051-1054.
39. Baumann MA, Menitove JE, Aster RH, Anderson T. Urgent treatment of idiopathic thrombocytopenic purpura with single dose gamma globulin infusion followed by platelet transfusion. Ann Intern Med 1986; 104:808-809.
40. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75:1383-1395.
41. Khurana MS, Lian EC, Harkness DR. "Storage pool disease" of platelets. Association with multiple congenital cavernous hemangiomas. JAMA 1980; 244:169-171.
42. Gordon LI, Kwaan HC, Rossi EC. Deleterious effects of platelet transfusions and recovery thtombocytosis in patients with thrombotic microangiopathy. Semin Hematol 1987; 24:194-201.
43. Harkness DR, Byrnes JS, Lian ECY, Williams WD, Hensley GT. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 1981; 246:1931-1933.
44. Rintels PB, Kenney RM, Crowley JP. Therapeutic support of the patient with thrombocytopenia [review]. Hematol Oncol Clin North Am 1994, 8(6):1131-1157.